Condition

Hormone Receptor Positive clinical trials and research

• 2Clinical trials
• 9Countries

All recruiting trials (2)

• HER3-DXd and T-DXd combo therapy in HR-positive, HER2-low/ultralow breast cancer

  This trial tests a combination of patritumab deruxtecan and trastuzumab deruxtecan in people with HR-positive, HER2-low or HER2-ultralow unresectable or metastatic breast cancer to see if it is safe and shows anti-tumor activity.

  Recruiting at 7 sites Phase 1/2 Daiichi Sankyo · Los Angeles, California and 71 other locations · NCT07701941

• Ablation versus breast-conserving surgery for early hormone receptor–positive breast cancer

  This trial will test whether a minimally invasive hybrid cryo-thermal ablation works as well as breast-conserving surgery for women aged 50 and older with a single, small ER/PR-positive, HER2-negative early breast cancer.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07484087

Related topics

Quick answers

How many Hormone Receptor Positive clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in Belgium (1 trial), France (1 trial), Italy (1 trial), Japan (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →